A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver

Biochimie

Volumn 93, Issue 5, 2011, Pages 876-891

  Fidaleo, Marco ^a,b,f   Arnauld, Ségolène ^a,b   Clémencet, Marie Claude ^a,b   Chevillard, Grégory ^a,b,g   Royer, Marie Charlotte ^a,b   De Bruycker, Melina ^c   Wanders, Ronald J A ^d   Athias, Anne ^b   Gresti, Joseph ^a   Clouet, Pierre ^a   Degrace, Pascal ^a   Kersten, Sander ^e   Espeel, Marc ^c   Latruffe, Norbert ^a,b   Nicolas Francès, Valérie ^a,b   Mandard, Stéphane ^a,b  

^a boulevard Jeanne d'Arc   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

Cholesterol; Micro array analysis; Peroxisomal 3 ketoacyl CoA thiolase B; PPAR and SREBP 2; Wy14,643

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ACYL COENZYME A OXIDASE; CATALASE; CHOLESTEROL; LATHOSTEROL; MESSENGER RNA; PALMITIC ACID; PEROXISOMAL 3 KETOACYL COA THIOLASE B; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOCHEMISTRY; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE CONTROL; GENE TARGETING; GENOTYPE; LIPID BLOOD LEVEL; LIVER; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PEROXISOME; PROTEIN MICROARRAY; UPREGULATION;

MUS;

EID: 79953874208     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2011.02.001     Document Type: Article

References (78)

1. R.J. Wanders, S. Ferdinandusse, P. Brites, S. Kemp, Peroxisomes, lipid metabolism and lipotoxicity, Biochim. Biophys. Acta 1801 (2010) 272-280.
2. G. Chevillard, M.C. Clemencet, P. Etienne, P. Martin, T. Pineau, N. Latruffe, V. Nicolas-Frances, Molecular cloning, gene structure and expression profile of twomouse peroxisomal 3-ketoacyl-CoA thiolase genes, BMCBiochem. 5 (2004) 3.
3. M. Hijikata, J.K. Wen, T. Osumi, T. Hashimoto, Rat peroxisomal 3-ketoacyl-CoA thiolase gene. Occurrence of two closely related but differentially regulated genes, J. Biol. Chem. 265 (1990) 4600-4606.
4. A. Bout, M.M. Franse, J. Collins, L. Blonden, J.M. Tager, R. Benne, Characterization of the gene encoding human peroxisomal 3-oxoacyl-CoA thiolase (ACAA). No large DNA rearrangement in a thiolase-deficient patient, Biochim. Biophys. Acta 1090 (1991) 43-51.
5. Y. Poirier, V.D. Antonenkov, T. Glumoff, J.K. Hiltunen, Peroxisomal beta-oxidation-a metabolic pathway with multiple functions, Biochim. Biophys. Acta 1763 (2006) 1413-1426.
6. U. Seedorf, M. Raabe, P. Ellinghaus, F. Kannenberg, M. Fobker, T. Engel, S. Denis, F. Wouters, K.W. Wirtz, R.J. Wanders, N. Maeda, G. Assmann, Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function, Genes Dev. 12 (1998) 1189-1201. (Pubitemid 28194054)
7. C.Y. Fan, J. Pan, R. Chu, D. Lee, K.D. Kluckman, N. Usuda, I. Singh, A.V. Yeldandi, M.S. Rao, N. Maeda, J.K. Reddy, Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene, J. Biol. Chem. 271 (1996) 24698-24710.
8. C.Y. Fan, J. Pan, N. Usuda, A.V. Yeldandi, M.S. Rao, J.K. Reddy, Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism, J. Biol. Chem. 273 (1998) 15639-15645.
9. S. Ferdinandusse, S. Denis, E.M. Hogenhout, J. Koster, C.W. van Roermund, L. IJIst, A.B. Moser, R.J. Wanders, H.R. Waterham, Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency, Hum. Mutat. 28 (2007) 904-912. (Pubitemid 47579941)
10. D. Oaxaca-Castillo, P. Andreoletti, A. Vluggens, S. Yu, P.P. van Veldhoven, J.K. Reddy, M. Cherkaoui-Malki, Biochemical characterization of two functional human liver acyl-CoA oxidase isoforms 1a and 1b encoded by a single gene, Biochem. Biophys. Res. Commun. 360 (2007) 314-319. (Pubitemid 47030347)
11. A. Vluggens, P. Andreoletti, N. Viswakarma, Y. Jia, K. Matsumoto, W. Kulik, M. Khan, J. Huang, D. Guo, S. Yu, J. Sarkar, I. Singh, M.S. Rao, R.J. Wanders, J.K. Reddy, M. Cherkaoui-Malki, Functional significance of the two ACOX1 isoforms and their crosstalks with PPARalpha and RXRalpha, Lab. Invest. 90 (2010) 696-708.
12. M. Baes, S. Huyghe, P. Carmeliet, P.E. Declercq, D. Collen, G.P. Mannaerts, P.P. Van Veldhoven, Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids, J. Biol. Chem. 275 (2000) 16329-16336.
13. C. Qi, Y. Zhu, J. Pan, N. Usuda, N. Maeda, A.V. Yeldandi, M.S. Rao, T. Hashimoto, J.K. Reddy, Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism, J. Biol. Chem. 274 (1999) 15775-15780.
14. K. Martens, E. Ver Loren van Themaat, M.F. van Batenburg, M. Heinaniemi, S. Huyghe, P. Van Hummelen, C. Carlberg, P.P. Van Veldhoven, A. Van Kampen, M. Baes, Coordinate induction of PPARalpha and SREBP2 in multifunctional protein 2 deficient mice, Biochim. Biophys. Acta (2008).
15. S. Ferdinandusse, E.G. van Grunsven, W. Oostheim, S. Denis, E.M. Hogenhout, L. IJIst, C.W. van Roermund, H.R. Waterham, S. Goldfischer, R.J. Wanders, Reinvestigation of peroxisomal 3-ketoacyl-CoA thiolase deficiency: identification of the true defect at the level of d-bifunctional protein, Am. J. Hum. Genet. 70 (2002) 1589-1593. (Pubitemid 34533907)
16. A.W. Schram, S. Goldfischer, C.W. van Roermund, E.M. Brouwer-Kelder, J. Collins, T. Hashimoto, H.S. Heymans, H. van den Bosch, R.B. Schutgens, J.M. Tager, et al., Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency, Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 2494-2496. (Pubitemid 17075892)
17. G. Chevillard, M.C. Clemencet, N. Latruffe, V. Nicolas-Frances, Targeted disruption of the peroxisomal thiolase B gene in mouse: a new model to study disorders related to peroxisomal lipid metabolism, Biochimie 86 (2004) 849-856. (Pubitemid 39610528)
18. J.K. Reddy, T.P. Krishnakantha, Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate, Science 190 (1975) 787-789.
19. S.S. Lee, T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal, F.J. Gonzalez, Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators, Mol. Cell. Biol. 15 (1995) 3012-3022.
20. I. Issemann, S. Green, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature 347 (1990) 645-650.
21. P.R. Devchand, H. Keller, J.M. Peters, M. Vazquez, F.J. Gonzalez, W. Wahli, The PPARalpha-leukotriene B4 pathway to inflammation control, Nature 384 (1996) 39-43.
22. P. Escher, O. Braissant, S. Basu-Modak, L. Michalik, W. Wahli, B. Desvergne, Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding, Endocrinology 142 (2001) 4195-4202. (Pubitemid 32907045)
23. S. Mandard, M. Muller, S. Kersten, Peroxisome proliferator-activated receptor alpha target genes, Cell Mol. Life Sci. 61 (2004) 393-416.
24. F. Hansmannel, M.C. Clemencet, C. Le Jossic-Corcos, T. Osumi, N. Latruffe, V. Nicolas-Frances, Functional characterization of a peroxisome proliferator response-element located in the intron 3 of rat peroxisomal thiolase B gene, Biochem. Biophys. Res. Commun. 311 (2003) 149-155. (Pubitemid 37297899)
25. V. Nicolas-Frances, V.K. Dasari, E. Abruzzi, T. Osumi, N. Latruffe, The peroxisome proliferator response element (PPRE) present at positions -681/-669 in the rat liver 3-ketoacyl-CoA thiolase B gene functionally interacts differently with PPARalpha and HNF-4, Biochem. Biophys. Res. Commun. 269 (2000) 347-351. (Pubitemid 30440301)
26. B. Desvergne, W. Wahli, Peroxisome proliferator-activated receptors: nuclear control of metabolism, Endocr. Rev. 20 (1999) 649-688.
27. F.J. Gonzalez, Y.M. Shah, PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators, Toxicology 246 (2008) 2-8.
28. R. Genolet, W. Wahli, L. Michalik, PPARs as drug targets to modulate inflammatory responses? Curr. Drug Targets Inflamm. Allergy 3 (2004) 361-375. (Pubitemid 39534773)
29. R. Stienstra, S. Mandard, N.S. Tan, W. Wahli, C. Trautwein, T.A. Richardson, E. Lichtenauer-Kaligis, S. Kersten, M. Muller, The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver, J. Hepatol. 46 (2007) 869-877. (Pubitemid 46529035)
30. M. Cherkaoui-Malki, K. Meyer, W.Q. Cao, N. Latruffe, A.V. Yeldandi, M.S. Rao, C.A. Bradfield, J.K. Reddy, Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis, Gene Expr. 9 (2001) 291-304. (Pubitemid 33096400)
31. L.M. Sanderson, P.J. de Groot, G.J. Hooiveld, A. Koppen, E. Kalkhoven, M. Muller, S. Kersten, Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics, PLoS One 3 (2008) e1681.
32. Z.Y. Du, L. Demizieux, P. Degrace, J. Gresti, B. Moindrot, Y.J. Liu, L.X. Tian, J.M. Cao, P. Clouet, Alteration of 20:5n-3 and 22:6n-3 fat contents and liver peroxisomal activities in fenofibrate-treated rainbow trout, Lipids 39 (2004) 849-855. (Pubitemid 40030377)
33. P. Degrace, L. Demizieux, J. Gresti, J.M. Chardigny, J.L. Sebedio, P. Clouet, Hepatic steatosis is not due to impaired fatty acid oxidation capacities in C57BL/6J mice fed the conjugated trans-10, cis-12-isomer of linoleic acid, J. Nutr. 134 (2004) 861-867. (Pubitemid 38456255)
34. H. Weissbach, T.E. Smith, J.W. Daly, B. Witkop, S. Udenfriend, A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine, J. Biol. Chem. 235 (1960) 1160-1163.
35. J.B. Robinson Jr., P.A. Srere, Organization of Krebs tricarboxylic acid cycle enzymes in mitochondria, J. Biol. Chem. 260 (1985) 10800-10805.
36. M. Bronfman, N.C. Inestrosa, F. Leighton, Fatty acid oxidation by human liver peroxisomes, Biochem. Biophys. Res. Commun. 88 (1979) 1030-1036. (Pubitemid 9204826)
37. F. Roels, B. De Prest, G. De Pestel, Liver and chorion cytochemistry, J. Inherit. Metab. Dis. 18 (Suppl. 1) (1995) 155-171. (Pubitemid 26046032)
38. I. Kerckaert, D. De Craemer, G. Van Limbergen, Practical guide for morphometry of human peroxisomes on electron micrographs, J. Inherit. Metab. Dis. 18 (Suppl. 1) (1995) 172-180. (Pubitemid 26046033)
39. S. Mandard, R. Stienstra, P. Escher, N.S. Tan, I. Kim, F.J. Gonzalez, W. Wahli, B. Desvergne, M. Muller, S. Kersten, Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors, Cell. Mol. Life Sci. 64 (2007) 1145-1157. (Pubitemid 46684553)
40. G. Denis, S. Mandard, C. Humblet, M. Verlaet, J. Boniver, D. Stehelin, M.P. Defresne, D. Regnier, Nuclear localization of a new c-cbl related protein, CARP 90, during in vivo thymic apoptosis in mice, Cell. Death Differ. 6 (1999) 689-697. (Pubitemid 29366659)
41. S. Hogenboom, G.J. Romeijn, S.M. Houten, M. Baes, R.J. Wanders, H.R. Waterham, Absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis, J. Lipid Res. 43 (2002) 90-98.
42. S. Miyazawa, T. Osumi, T. Hashimoto, The presence of a new 3-oxoacyl-CoA thiolase in rat liver peroxisomes, Eur. J. Biochem. 103 (1980) 589-596.
43. M. Baarine, K. Ragot, E.C. Genin, H. El Hajj, D. Trompier, P. Andreoletti, M.S. Ghandour, F. Menetrier, M. Cherkaoui-Malki, S. Savary, G. Lizard, Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): potential models for the study of peroxisomal disorders associated with dysmyelination processes, J. Neurochem. 111 (2009) 119-131.
44. C. Le Jossic-Corcos, S. Duclos, L.C. Ramirez, I. Zaghini, G. Chevillard, P. Martin, T. Pineau, P. Bournot, Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes, Biochim. Biophys. Acta 1683 (2004) 49-58.
45. B.L. Knight, A. Hebbachi, D. Hauton, A.M. Brown, D. Wiggins, D.D. Patel, G.F. Gibbons, A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver, Biochem. J. 389 (2005) 413-421. (Pubitemid 41021145)
46. D.D. Hinson, K.L. Chambliss, M.J. Toth, R.D. Tanaka, K.M. Gibson, Posttranslational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways, J. Lipid Res. 38 (1997) 2216-2223. (Pubitemid 27495380)
47. H.J. Kempen, J.F. Glatz, J.A. Gevers Leuven, H.A. van der Voort, M.B. Katan, Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans, J. Lipid Res. 29 (1988) 1149-1155.
48. J.J. Hamilton, M. Phang, S.M. Innis, Elevation of plasma lathosterol, as an indicator of increased cholesterol synthesis, in preterm (23-32 weeks gestation) infants given intralipid, Pediatr. Res. 31 (1992) 186-192.
49. S. Arnauld, M. Fidaleo, M.C. Clemencet, G. Chevillard, A. Athias, J. Gresti, R.J. Wanders, N. Latruffe, V. Nicolas-Frances, S. Mandard, Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643, Biochimie 91 (2009) 1376-1386.
50. E. Baumgart, I. Vanhorebeek, M. Grabenbauer, M. Borgers, P.E. Declercq, H.D. Fahimi, M. Baes, Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse), Am. J. Pathol. 159 (2001) 1477-1494. (Pubitemid 32947977)
51. P.L. Faust, M.E. Hatten, Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder, J. Cell. Biol. 139 (1997) 1293-1305. (Pubitemid 27523215)
52. M. Funato, N. Shimozawa, T. Nagase, Y. Takemoto, Y. Suzuki, Y. Imamura, T. Matsumoto, T. Tsukamoto, T. Kojidani, T. Osumi, T. Fukao, N. Kondo, Aberrant peroxisome morphology in peroxisomal beta-oxidation enzyme deficiencies, Brain Dev. 28 (2006) 287-292.
53. M. Schrader, E. Baumgart, A. Volkl, H.D. Fahimi, Heterogeneity of peroxisomes in human hepatoblastoma cell line HepG2. Evidence of distinct subpopulations, Eur. J. Cell. Biol. 64 (1994) 281-294. (Pubitemid 24258188)
54. F. Roels, M. Pauwels, B.T. Poll-The, J. Scotto, H. Ogier, P. Aubourg, J.M. Saudubray, Hepatic peroxisomes in adrenoleukodystrophy and related syndromes: cytochemical and morphometric data, Virchows. Arch. A Pathol. Anat. Histopathol. 413 (1988) 275-285.
55. P. Brites, A.M. Motley, P. Gressens, P.A. Mooyer, I. Ploegaert, V. Everts, P. Evrard, P. Carmeliet, M. Dewerchin, L. Schoonjans, M. Duran, H.R. Waterham, R.J. Wanders, M. Baes, Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata, Hum. Mol. Genet. 12 (2003) 2255-2267. (Pubitemid 37160870)
56. V.D. Antonenkov, P.P. Van Veldhoven, E. Waelkens, G.P. Mannaerts, Comparison of the stability and substrate specificity of purified peroxisomal 3-oxoacyl-CoA thiolases A and B from rat liver, Biochim. Biophys. Acta 1437 (1999) 136-141.
57. Y. Jia, C. Qi, Z. Zhang, T. Hashimoto, M.S. Rao, S. Huyghe, Y. Suzuki, P.P. Van Veldhoven, M. Baes, J.K. Reddy, Overexpression of peroxisome proliferator-activated receptor-alpha (PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal beta-oxidation system, J. Biol. Chem. 278 (2003) 47232-47239.
58. R. Dirkx, E. Meyhi, S. Asselberghs, J. Reddy, M. Baes, P.P. Van Veldhoven, Betaoxidation in hepatocyte cultures from mice with peroxisomal gene knockouts, Biochem. Biophys. Res. Commun. 357 (2007) 718-723. (Pubitemid 46653839)
59. T. Kasumov, J.E. Adams, F. Bian, F. David, K.R. Thomas, K.A. Jobbins, P.E. Minkler, C.L. Hoppel, H. Brunengraber, Probing peroxisomal beta-oxidation and the labelling of acetyl-CoA proxies with [1-(13C)]octanoate and [3-(13C)]octanoate in the perfused rat liver, Biochem. J. 389 (2005) 397-401. (Pubitemid 41021143)
60. N. Aboushadi, W.H. Engfelt, V.G. Paton, S.K. Krisans, Role of peroxisomes in isoprenoid biosynthesis, J. Histochem. Cytochem. 47 (1999) 1127-1132.
61. W.J. Kovacs, K.N. Tape, J.E. Shackelford, X. Duan, T. Kasumov, J.K. Kelleher, H. Brunengraber, S.K. Krisans, Localization of the pre-squalene segment of the isoprenoid biosynthetic pathway in mammalian peroxisomes, Histochem. Cell Biol. 127 (2007) 273-290.
62. I. Weinhofer, M. Kunze, H. Stangl, F.D. Porter, J. Berger, Peroxisomal cholesterol biosynthesis and Smith-Lemli-Opitz syndrome, Biochem. Biophys. Res. Commun. 345 (2006) 205-209.
63. W.J. Kovacs, K.N. Tape, J.E. Shackelford, T.M. Wikander, M.J. Richards, S.J. Fliesler, S.K. Krisans, P.L. Faust, Peroxisome deficiency causes a complex phenotype because of hepatic SREBP/Insig dysregulation associated with endoplasmic reticulum stress, J. Biol. Chem. 284 (2009) 7232-7245.
64. D.L. van der Meer, T. Degenhardt, S. Vaisanen, P.J. de Groot, M. Heinaniemi, S.C. de Vries, M. Muller, C. Carlberg, S. Kersten, Profiling of promoter occupancy by PPAR{alpha} in human hepatoma cells via ChIP-chip analysis, Nucleic Acids Res. (2010).
65. N. Leuenberger, S. Pradervand, W. Wahli, Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice, J. Clin. Invest. 119 (2009) 3138-3148.
66. J.D. Horton, J.L. Goldstein, M.S. Brown, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest. 109 (2002) 1125-1131.
67. J.D. Horton, I. Shimomura, Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis, Curr. Opin. Lipidol. 10 (1999) 143-150.
68. J.D. Horton, I. Shimomura, M.S. Brown, R.E. Hammer, J.L. Goldstein, H. Shimano, Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2, J. Clin. Invest. 101 (1998) 2331-2339.
69. H. Shimano, J.D. Horton, I. Shimomura, R.E. Hammer, M.S. Brown, J.L. Goldstein, Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells, J. Clin. Invest. 99 (1997) 846-854.
70. M. Arito, T. Horiba, S. Hachimura, J. Inoue, R. Sato, Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expression of their target genes, low density lipoprotein uptake, and lipid synthesis, J. Biol. Chem. 283 (2008) 15224-15231.
71. M. Rakhshandehroo, L.M. Sanderson, M. Matilainen, R. Stienstra, C. Carlberg, P.J. de Groot, M. Muller, S. Kersten, Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling, PPAR Res. 2007 (2007) 26839.
72. Y. Wang, P.M. Rogers, C. Su, G. Varga, K.R. Stayrook, T.P. Burris, Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha, J. Biol. Chem. 283 (2008) 26332-26339.
73. K.A. Tobin, H.H. Steineger, S. Alberti, O. Spydevold, J. Auwerx, J.A. Gustafsson, H.I. Nebb, Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha, Mol. Endocrinol. 14 (2000) 741-752.
74. J. Lengqvist, A. Mata De Urquiza, A.C. Bergman, T.M. Willson, J. Sjovall, T. Perlmann, W.J. Griffiths, Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligandbinding domain, Mol. Cell. Proteomics 3 (2004) 692-703.
75. H. Cao, K. Gerhold, J.R. Mayers, M.M. Wiest, S.M. Watkins, G.S. Hotamisligil, Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism, Cell 134 (2008) 933-944.
76. M.T. Flowers, M.P. Keller, Y. Choi, H. Lan, C. Kendziorski, J.M. Ntambi, A.D. Attie, Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet, Physiol. Genomics 33 (2008) 361-372. (Pubitemid 352755738)
77. C.M. Paton, J.M. Ntambi, Loss of stearoyl-CoA desaturase activity leads to free cholesterol synthesis through increased Xbp-1 splicing, Am. J. Physiol. Endocrinol. Metab. (2010).
78. W.J. Kovacs, J.E. Shackelford, K.N. Tape, M.J. Richards, P.L. Faust, S.J. Fliesler, S.K. Krisans, Disturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse model, Mol. Cell. Biol. 24 (2004) 1-13. (Pubitemid 38010030)